These include Alzheimers Disease, Infertility, Depression, and Diabetes
People who are pregnant or breastfeeding should avoid GLP-1 medication , and certain health conditions may make this type of weight loss treatment unsafe
Study design and study population We identified three study cohorts of patients who started SGLT-2 inhibitors versus DPP-4 inhibitors (cohort 1), GLP-1 receptor agonists versus DPP-4 inhibitors (cohort 2), and SGLT-2 inhibitors versus GLP-1 receptor agonists (cohort 3) from April 2013 to the end of available data (December 2019 in Medicare, December 2020 in MarketScan, and April 2022 in CDM)
A The results showed that early re-engagement with weight loss efforts, including restarting WW plans, consistent self-monitoring, and remaining on top of their dietary intake, helped people limit their weight regain
Some may be linked to the indirect effects of rapid weight loss, such as muscle loss and joint instability
All USD conversions will be automatically applied to customers credit card statement